Block length-dependent protein fouling on Poly(2-oxazoline)-based polymersomes: influence on macrophage association and circulation behavior

Polymersomes are vesicular structures self-assembled from amphiphilic block copolymers and are considered an alternative to liposomes for applications in drug delivery, immunotherapy, biosensing, and as nanoreactors and artificial organelles. However, the limited availability of systematic stability, protein fouling (protein corona formation), and blood circulation studies hampers their clinical translation. Poly(2-oxazoline)s (POx) are valuable antifouling hydrophilic polymers that can replace the current gold-standard, poly(ethylene glycol) (PEG), yet investigations of POx functionality on nanoparticles are relatively sparse. Herein, a systematic study is reported of the structural, dynamic and antifouling properties of polymersomes made of poly(2-methyl-2-oxazoline)-block-poly(dimethylsiloxane)-block-poly(2-methyl-2-oxazoline) (PMOXA-b-PDMS-b-PMOXA). The study relates in vitro antifouling performance of the polymersomes to atomistic molecular dynamics simulations of polymersome membrane hydration behavior. These observations support the experimentally demonstrated benefit of maximizing the length of PMOXA (degree of polymerization (DP) > 6) while keeping PDMS at a minimal length that still provides sufficient membrane stability (DP > 19). In vitro macrophage association and in vivo blood circulation evaluation of polymersomes in zebrafish embryos corroborate these findings. They further suggest that single copolymer presentation on polymersomes is outperformed by blends of varied copolymer lengths. This study helps to rationalize design rules for stable and low-fouling polymersomes for future medical applications

Photochemical internalization enhanced vaccination is safe, and gives promising cellular immune responses to an HPV peptide-based vaccine in a phase I clinical study in healthy volunteers

Background and Aims: Photochemical internalization (PCI) is a technology for inducing release of endocytosed antigens into the cell cytosol via a light-induced process. Preclinical experiments have shown that PCI improves MHC class I antigen presentation, resulting in strongly enhanced CD8+ T-cell responses to polypeptide antigens. In PCI vaccination a mixture of the photosensitizing compound fimaporfin, vaccine antigens, and an adjuvant is administered intradermally followed by illumination of the vaccination site. This work describes an open label, phase I study in healthy volunteers, to assess the safety, tolerability, and immune response to PCI vaccination in combination with the adjuvant poly-ICLC (Hiltonol) (ClinicalTrials.gov Identifier: NCT02947854).Methods: The primary objective of the study was to assess the safety and local tolerance of PCI mediated vaccination, and to identify a safe fimaporfin dose for later clinical studies. A secondary objective was to analyze the immunological responses to the vaccination. Each subject received 3 doses of HPV16 E7 peptide antigens and two doses of Keyhole Limpet Hemocyanin (KLH) protein. A control group received Hiltonol and vaccine antigens only, whereas the PCI groups in addition received fimaporfin + light. Local and systemic adverse effects were assessed by standard criteria, and cellular and humoral immune responses were analyzed by ELISpot, flow cytometry, and ELISA assays.Results: 96 healthy volunteers were vaccinated with fimaporfin doses of 0.75-50 mu g. Doses below 17.5 mu g were safe and tolerable, higher doses exhibited local tolerability issues in some study subjects, mainly erythema, and pain during illumination. There were few, and only mild and expected systemic adverse events. The employment of PCI increased the number of subjects exhibiting a T-cell response to the HPV peptide vaccine about 10-fold over what was achieved with the antigen/Hiltonol combination without PCI. Moreover, the use of PCI seemed to result in a more consistent and multifunctional CD8+ T-cell response. An enhancement of the humoral immune response to KLH vaccination was also observed.Conclusions: Using PCI in combination with Hiltonol for intradermal vaccination is safe at fimaporfin doses below 17.5 mu g, and gives encouraging immune responses to peptide and protein based vaccination.Experimental cancer immunology and therap

Modular synthesis of semiconducting graft co-polymers to achieve ‘clickable’ fluorescent nanoparticles with long circulation and specific cancer targeting

Semiconducting polymer nanoparticles (SPNs) are explored for applications in cancer theranostics because of their high absorption coefficients, photostability, and biocompatibility. However, SPNs are susceptible to aggregation and protein fouling in physiological conditions, which can be detrimental for in vivo applications. Here, a method for achieving colloidally stable and low-fouling SPNs is described by grafting poly(ethylene glycol) (PEG) onto the backbone of the fluorescent semiconducting polymer, poly(9,9′-dioctylfluorene-5-fluoro-2,1,3-benzothiadiazole), in a simple one-step substitution reaction, postpolymerization. Further, by utilizing azide-functionalized PEG, anti-human epidermal growth factor receptor 2 (HER2) antibodies, antibody fragments, or affibodies are site-specifically “clicked” onto the SPN surface, which allows the functionalized SPNs to specifically target HER2-positive cancer cells. In vivo, the PEGylated SPNs are found to have excellent circulation efficiencies in zebrafish embryos for up to seven days postinjection. SPNs functionalized with affibodies are then shown to be able to target HER2 expressing cancer cells in a zebrafish xenograft model. The covalent PEGylated SPN system described herein shows great potential for cancer theranostics

Low Levels of DNA Polymerase Alpha Induce Mitotic and Meiotic Instability in the Ribosomal DNA Gene Cluster of Saccharomyces cerevisiae

The ribosomal DNA (rDNA) genes of Saccharomyces cerevisiae are located in a tandem array of about 150 repeats. Using a diploid with markers flanking and within the rDNA array, we showed that low levels of DNA polymerase alpha elevate recombination between both homologues and sister chromatids, about five-fold in mitotic cells and 30-fold in meiotic cells. This stimulation is independent of Fob1p, a protein required for the programmed replication fork block (RFB) in the rDNA. We observed that the fob1 mutation alone significantly increased meiotic, but not mitotic, rDNA recombination, suggesting a meiosis-specific role for this protein. We found that meiotic cells with low polymerase alpha had decreased Sir2p binding and increased Spo11p-catalyzed double-strand DNA breaks in the rDNA. Furthermore, meiotic crossover interference in the rDNA is absent. These results suggest that the hyper-Rec phenotypes resulting from low levels of DNA polymerase alpha in mitosis and meiosis reflect two fundamentally different mechanisms: the increased mitotic recombination is likely due to increased double-strand DNA breaks (DSBs) resulting from Fob1p-independent stalled replication forks, whereas the hyper-Rec meiotic phenotype results from increased levels of Spo11-catalyzed DSBs in the rDNA

Multi-Modality Therapeutics with Potent Anti-Tumor Effects: Photochemical Internalization Enhances Delivery of the Fusion Toxin scFvMEL/rGel

BACKGROUND: There is a need for drug delivery systems (DDS) that can enhance cytosolic delivery of anti-cancer drugs trapped in the endo-lysosomal compartments. Exposure of cells to specific photosensitizers followed by light exposure (photochemical internalization, PCI) results in transfer of agents from the endocytic compartment into the cytosol. METHODOLOGY AND PRINCIPAL FINDINGS: The recombinant single-chain fusion construct scFvMEL/rGel is composed of an antibody targeting the progenitor marker HMW-MAA/NG2/MGP/gp240 and the highly effective toxin gelonin (rGel). Here we demonstrate enhanced tumor cell selectivity, cytosolic delivery and anti-tumor activity by applying PCI of scFvMEL/rGel. PCI performed by light activation of cells co-incubated with scFvMEL/rGel and the endo-lysosomal targeting photosensitizers AlPcS(2a) or TPPS(2a) resulted in enhanced cytotoxic effects against antigen-positive cell lines, while no differences in cytotoxicity between the scFvMEL/rGel and rGel were observed in antigen-negative cells. Mice bearing well-developed melanoma (A-375) xenografts (50-100 mm(3)) were treated with PCI of scFvMEL/rGel. By 30 days after injection, approximately 100% of mice in the control groups had tumors>800 mm(3). In contrast, by day 40, 50% of mice in the PCI of scFvMEL/rGel combination group had tumors<800 mm(3) with no increase in tumor size up to 110 days. PCI of scFvMEL/rGel resulted in a synergistic effect (p<0.05) and complete regression (CR) in 33% of tumor-bearing mice (n = 12). CONCLUSIONS/SIGNIFICANCE: This is a unique demonstration that a non-invasive multi-modality approach combining a recombinant, targeted therapeutic such as scFvMEL/rGel and PCI act in concert to provide potent in vivo efficacy without sacrificing selectivity or enhancing toxicity. The present DDS warrants further evaluation of its clinical potential

Time-domain evaluation of drug-solvent interactions of the photosensitizers TPCS2a and TPPS2a as part of physicochemical characterization

The patented photosensitizer meso-tetraphenyl chlorin disulphonate (TPCS2a) is intended for use in the technology of photochemical internalization (PCI). The compound is advantageous with respect to the related meso-tetraphenyl porphyrin disulphonate (TPPS2a), due to its high absorption in the red part of the absorption spectrum (λabs ≈ 650 nm). We report a time-resolved fluorescence study of TPCS2a aimed to elucidate the susceptibility of the photosensitizer's excited state dynamics to properties of its environment, such as polarity and hydrogen bond formation. TPPS2a is used as a reference compound. Fluorescence decays with &lt;30 ps temporal resolution of TPCS2a and TPPS 2a in 14 organic solvents of varying polarity and amphiprotic properties were measured by time-correlated single-photon counting (TCSPC). Both compounds show triple exponential fluorescence decays in non-polar environment, i.e. τL ∼ 7 ns, τI ∼ 2 ns and τS ∼ 0.5 ns. The two shorter decay components, τI and τS, which we associated with two different intramolecular charge transfer mechanisms, readily disappear when the solvent polarity is slightly increased. The fluorescence decays of both compounds in any solvent of dielectric constant ε &gt; 7.58 are well fitted by a single exponential model, with decay time roughly constant, τL ∼ 10 ns, and independent of the amphiprotic properties of the solvents. The present results allow concluding that the fluorescence decay pathways of TPCS 2a and TPPS2a are only slightly affected by the environmental properties under consideration, as previously probed by steady-state measurements (Lilletvedt et al. [1]). Singlet oxygen ( 1O2) generation of the two photosensitizers were measured indirectly in water by applying the singlet oxygen sensor green (SOSG) reagent. Both photosensitizers generate 1O2 to some extent upon excitation in vitro. © 2010 Elsevier B.V

Physicochemical characterization of the photosensitizers TPCS 2aand TPPS2a 1. Spectroscopic evaluation of drug - Solvent interactions

The spectroscopic properties of the patented photosensitizer meso-tetraphenyl chlorin disulphonate (TPCS2a), intended for use in photochemical internalization (PCI) technology, and the chemically related photosensitizer meso-tetraphenyl porphyrin disulphonate (TPPS2a) were characterized in 14 organic solvents of varying polarity and amphiprotic properties. Absorption spectra and fluorescence emission spectra were acquired, and Stokes' shifts and fluorescence quantum yields determined. These investigations yield information on the physicochemical interactions between the photosensitizers and their surroundings (i.e., the physiological environment in vivo or the vehicle in vitro), which is essential for the further development of drug formulations. TPPS2a and TPCS2a are rigid molecules, built up by conjugated ring systems which possess limited interactions with the surroundings in the ground state (S0). Accordingly, only small spectral shifts were observed in the absorption spectra, as well as in the fluorescence emission spectra. TPPS2a is spatially more planar than TPCS2a, which is twisted as a result of reduction of a double bond in the core. However, the two compounds were quite similarly influenced by properties of the solvents, indicating that twisting has limited importance in the interactions of the two photosensitizers with their environment. Both compounds possess a high character of π-π* transition upon light exposure, supported by high molar absorption coefficients. The fluorescence quantum yields (Φf) were influenced by solvent properties to a larger extent than the spectral shifts. This might indicate that the reactivity of the first excited singlet state (S1*) significantly depends on the properties of the surroundings

Solubilization of the photosensitizers TPCS2a and TPPS 2a in aqueous media evaluated by time-resolved fluorescence analysis

The pH-dependent aggregation of the novel photosensitizer TPCS2a is investigated at low concentration (c=10-6 M) in aqueous media by means of time-correlated single-photon counting, and compared to that of the chemically related photosensitizer TPPS2a. The efficacy of selected solubilizers, i.e., various nonionic Pluronic block copolymers and the nonionic surfactant Tween 80, in inhibiting aggregation of the two photosensitizers is evaluated, which is important for the further formulation of TPCS2a

Research data supporting "In Vivo Biomolecular Imaging of Zebrafish Embryos using Confocal Raman Spectroscopy"

Research raw data supporting Hogset et al., "In vivo biomolecular imaging of zebrafish embryos using confocal Raman spectroscopy", 2020, Nature Communications